Apollo Hospitals Enterprise Ltd
Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned architect of modern healthcare in India. As the nation’s first corporate hospital, Apollo Hospitals is acclaimed for pioneering the private healthcare revolution in the country.
Apollo Hospitals has emerged as Asia’s foremost integrated healthcare services provider and has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies,
Primary Care & Diagnostic Clinics and several Retail Health models. [1]
- Market Cap ₹ 88,796 Cr.
- Current Price ₹ 6,170
- High / Low ₹ 6,874 / 4,318
- Stock P/E 113
- Book Value ₹ 453
- Dividend Yield 0.24 %
- ROCE 14.5 %
- ROE 13.7 %
- Face Value ₹ 5.00
Pros
- Company has delivered good profit growth of 67.1% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 23.7%
Cons
- Stock is trading at 13.6 times its book value
- Company has a low return on equity of 11.7% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3,148 | 3,769 | 4,357 | 5,129 | 6,150 | 7,256 | 8,243 | 9,617 | 11,247 | 10,560 | 14,663 | 16,612 | 18,418 | |
2,631 | 3,157 | 3,681 | 4,392 | 5,465 | 6,522 | 7,442 | 8,548 | 9,656 | 9,420 | 12,474 | 14,548 | 16,179 | |
Operating Profit | 517 | 612 | 676 | 737 | 684 | 734 | 801 | 1,070 | 1,591 | 1,140 | 2,189 | 2,065 | 2,238 |
OPM % | 16% | 16% | 16% | 14% | 11% | 10% | 10% | 11% | 14% | 11% | 15% | 12% | 12% |
22 | 33 | 18 | 47 | 92 | 60 | 24 | 26 | 222 | 103 | 368 | 75 | 110 | |
Interest | 89 | 103 | 119 | 118 | 180 | 257 | 295 | 327 | 533 | 449 | 379 | 381 | 426 |
Depreciation | 124 | 142 | 168 | 212 | 264 | 314 | 359 | 396 | 620 | 573 | 601 | 615 | 656 |
Profit before tax | 326 | 399 | 407 | 455 | 332 | 222 | 171 | 373 | 660 | 221 | 1,578 | 1,144 | 1,266 |
Tax % | 35% | 26% | 25% | 29% | 29% | 41% | 65% | 47% | 34% | 38% | 30% | 22% | |
218 | 303 | 315 | 335 | 235 | 131 | 60 | 200 | 432 | 137 | 1,108 | 844 | 822 | |
EPS in Rs | 16.31 | 21.88 | 22.77 | 24.43 | 16.99 | 15.88 | 8.44 | 16.96 | 32.70 | 10.46 | 73.42 | 56.97 | 54.90 |
Dividend Payout % | 25% | 25% | 25% | 24% | 35% | 38% | 59% | 35% | 18% | 29% | 16% | 26% |
Compounded Sales Growth | |
---|---|
10 Years: | 16% |
5 Years: | 15% |
3 Years: | 14% |
TTM: | 16% |
Compounded Profit Growth | |
---|---|
10 Years: | 11% |
5 Years: | 67% |
3 Years: | 39% |
TTM: | 3% |
Stock Price CAGR | |
---|---|
10 Years: | 21% |
5 Years: | 37% |
3 Years: | 24% |
1 Year: | 42% |
Return on Equity | |
---|---|
10 Years: | 9% |
5 Years: | 10% |
3 Years: | 12% |
Last Year: | 14% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 67 | 70 | 70 | 70 | 70 | 70 | 70 | 70 | 70 | 72 | 72 | 72 | 72 |
Reserves | 2,401 | 2,677 | 2,907 | 3,102 | 3,262 | 3,244 | 3,182 | 3,264 | 3,270 | 4,531 | 5,551 | 6,126 | 6,437 |
817 | 1,213 | 1,344 | 1,992 | 2,834 | 3,125 | 3,427 | 3,673 | 3,596 | 4,160 | 4,068 | 4,332 | 4,889 | |
698 | 854 | 1,029 | 1,296 | 1,195 | 1,665 | 1,917 | 2,159 | 4,354 | 2,629 | 3,570 | 3,886 | 4,163 | |
Total Liabilities | 3,983 | 4,814 | 5,350 | 6,459 | 7,360 | 8,103 | 8,596 | 9,166 | 11,289 | 11,392 | 13,261 | 14,416 | 15,561 |
2,011 | 2,341 | 2,681 | 3,244 | 3,997 | 4,591 | 4,773 | 4,982 | 7,432 | 6,778 | 8,296 | 8,520 | 8,894 | |
CWIP | 209 | 403 | 491 | 533 | 562 | 347 | 712 | 822 | 236 | 234 | 46 | 610 | 727 |
Investments | 564 | 527 | 322 | 311 | 352 | 406 | 352 | 462 | 434 | 1,343 | 816 | 574 | 853 |
1,198 | 1,543 | 1,855 | 2,372 | 2,448 | 2,759 | 2,759 | 2,901 | 3,187 | 3,037 | 4,104 | 4,712 | 5,087 | |
Total Assets | 3,983 | 4,814 | 5,350 | 6,459 | 7,360 | 8,103 | 8,596 | 9,166 | 11,289 | 11,392 | 13,261 | 14,416 | 15,561 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
387 | 443 | 373 | 470 | 597 | 623 | 537 | 905 | 1,293 | 1,265 | 1,696 | 1,377 | |
-468 | -733 | -356 | -759 | -888 | -1,152 | -405 | -711 | -289 | -880 | -747 | -857 | |
135 | 373 | -63 | 392 | 330 | 477 | -108 | -215 | -910 | -340 | -792 | -633 | |
Net Cash Flow | 54 | 83 | -46 | 103 | 39 | -52 | 24 | -20 | 94 | 44 | 158 | -113 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 45 | 46 | 44 | 43 | 36 | 38 | 37 | 39 | 33 | 46 | 44 | 49 |
Inventory Days | 45 | 43 | 47 | 50 | 49 | 47 | 51 | 46 | 49 | 16 | 21 | 17 |
Days Payable | 58 | 53 | 55 | 59 | 66 | 51 | 55 | 56 | 60 | 74 | 79 | 82 |
Cash Conversion Cycle | 31 | 36 | 36 | 34 | 19 | 34 | 33 | 29 | 22 | -12 | -14 | -16 |
Working Capital Days | 18 | 17 | 28 | 30 | 27 | 30 | 25 | 16 | 9 | 12 | 13 | 18 |
ROCE % | 14% | 13% | 12% | 12% | 9% | 8% | 7% | 10% | 14% | 8% | 17% | 14% |
Documents
Announcements
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 16 Apr
- Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Submission Of Proceedings Of Annual General Meeting Of The Company Held On 30Th August 2023. Ref : Your Mail Dated 6Th April 2024 6 Apr
-
Announcement under Regulation 30 (LODR)-Change in Directorate
4 Apr - In response to the query raised by BSE on 3rd April 2024, the clarification provided by the company on corporate announcement submitted on 2nd April …
- Certificate Under Regulation 7(3) Of The SEBI (LODR) Regulations, 2015 For The Period 1St April 2023 To 31St March 2024 4 Apr
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
4 Apr - Certificate under Regulation 74(5) for the period ended 31st March 2024 is enclosed
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2011
from nse
-
Financial Year 2010
from bse
Concalls
-
Feb 2024Transcript PPT REC
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022TranscriptNotesPPT
-
Aug 2022TranscriptNotesPPT
-
May 2022TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021Transcript PPT
-
Jun 2021TranscriptNotesPPT
-
Jun 2021TranscriptNotesPPT
-
Jun 2021TranscriptNotesPPT
-
Nov 2020TranscriptPPT
-
Sep 2020TranscriptPPT
-
Jun 2020TranscriptPPT
-
Feb 2020TranscriptPPT
-
Nov 2019TranscriptPPT
-
Aug 2019TranscriptPPT
-
May 2019Transcript PPT
-
Feb 2019TranscriptPPT
-
Nov 2018TranscriptPPT
-
Aug 2018TranscriptPPT
-
May 2018TranscriptPPT
-
Feb 2018TranscriptPPT
-
Nov 2017TranscriptPPT
-
Aug 2017TranscriptPPT
-
Apr 2017Transcript PPT
-
Nov 2016TranscriptPPT
-
Feb 2016TranscriptPPT
-
Nov 2015TranscriptNotesPPT
Hospital segment metrics
Apollo Hospitals has facilities in large urban centers such as Chennai, Hyderabad, Kolkata, Bengaluru, New Delhi, Ahmedabad, Mumbai, Pune, Bhubaneshwar, Madurai and Mysore.
As of Q1FY24, 43 are owned and 6 are managed hospitals, with 9500+ beds, 62% occupancy rate, Rs. 57,760 / day ARPOB and 133,846 In-patients.[1]